Simon joined us in 2021 after consulting for Corporates seeking to develop partnership with Digital Health companies. He worked closely with business development functions to identify, assess, and structure strategic investments. Prior to that, Simon was at Baxter International, where he was part of the External Innovation Department. At Baxter, Simon coordinated scouting activities and technical due diligence that assessed M&A opportunities.
He is a Board member at Gradientech AB, a privately held Swedish company developing ultra-rapid treatment decision tools for antibiotic susceptibility testing. He is also a Steering Committee member of the MedFIT conference, an international event that brings together key innovators in the MedTech, diagnostic and digital health sectors.
Simon enjoys constant exposure to novel technologies, curious and motivated people, and supporting the development of companies that are striving to improve medicine. He decided to join Sofinnova because of the strong team spirit and collective drive.
He has a B.Sc. in Biomedical Science from King’s College London and an M.Sc. in International Business from SKEMA Business School.